RING CHRISTINE (General Counsel) sold 42.5% of their position (37.60K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $641.7K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/24/2025ACC: 0001817199-25-000007
Officer· General Counsel
Since Jul 2020
-37.60K
Net shares
Net seller
$641.7K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
37.60K acquired · 75.20K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+37.60K
Price / share
$1.86
Trade value
$69.94K
% of position
73.9%
11/24/2025
50.90K→88.50K
Common Stock
Direct
Shares
−37.60K
Price / share
$17.07
Trade value
$641.70K
% of position
42.5%
11/24/2025
88.50K→50.90K
Total
Net shares
+0.00
Net value
-$571.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/24/2025 | M · Option Exercise | +37.60K | $1.86 | $69.94K | 73.9% | 50.90K | 88.50K |
| Common Stock Direct | 11/24/2025 | S · Sale | −37.60K | $17.07 | $641.70K | 42.5% | 88.50K | 50.90K |
| Total | +0.00 | -$571.76K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
37.60K shares
Shares
−37.60K
Strike price
1.86
Held after
16.16K
Exercisable
—
11/24/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock37.60K shares | 11/24/2025 | M · Option Exercise | −37.60K | 1.86 | — | 16.16K |